Nanina Anderegg1, Leigh F Johnson, Elizabeth Zaniewski, Keri N Althoff, Eric Balestre, Matthew Law, Denis Nash, Bryan E Shepherd, Constantin T Yiannoutsos, Matthias Egger. 1. aInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland bCentre for Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa cJohn Hopkins University, Baltimore, Maryland, USA dISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Université Bordeaux, Bordeaux Cedex, France eKirby Institute, UNSW, Sydney, New South Wales, Australia fInstitute for Implementation Science in Population Health, City University of New York, New York, USA gDepartment of Epidemiology and Biostatistics, City University of New York School of Public Health, New York, New York, USA hDepartment of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA iDepartment of Biostatistics, Indiana University School of Public Health, Indianapolis, Indiana, USA.
Abstract
OBJECTIVE: To estimate mortality in HIV-positive patients starting combination antiretroviral therapy (ART) and to discuss different approaches to calculating correction factors to account for loss to follow-up. METHODS: A total of 222 096 adult HIV-positive patients who started ART 2009-2014 in clinics participating in the International epidemiology Databases to Evaluate AIDS collaboration in 43 countries in sub-Saharan Africa, Asia Pacific, Latin America, and North America were included. To allow for underascertainment of deaths due to loss to follow-up, two correction factors (one for the period 0-6 months on ART and one for later periods) or 168 correction factors (combinations of two sexes, three time periods after ART initiation, four age groups, and seven CD4 groups) based on tracing patients lost in Kenya and data linkages in South Africa were applied. Corrected mortality rates were compared with a worst case scenario assuming all patients lost to follow-up had died. RESULTS: Loss to follow-up differed between regions; rates were lowest in central Africa and highest in east Africa. Compared with using two correction factors (1.64 for the initial ART period and 2.19 for later), applying 168 correction factors (range 1.03-4.75) more often resulted in implausible mortality rates that exceeded the worst case scenario. Corrected mortality rates varied widely, ranging from 0.2 per 100 person-years to 54 per 100 person-years depending on region and covariates. CONCLUSION: Implausible rates were less common with the simpler approach based on two correction factors. The corrected mortality rates will be useful to international agencies, national programmes, and modellers.
OBJECTIVE: To estimate mortality in HIV-positivepatients starting combination antiretroviral therapy (ART) and to discuss different approaches to calculating correction factors to account for loss to follow-up. METHODS: A total of 222 096 adult HIV-positivepatients who started ART 2009-2014 in clinics participating in the International epidemiology Databases to Evaluate AIDS collaboration in 43 countries in sub-Saharan Africa, Asia Pacific, Latin America, and North America were included. To allow for underascertainment of deaths due to loss to follow-up, two correction factors (one for the period 0-6 months on ART and one for later periods) or 168 correction factors (combinations of two sexes, three time periods after ART initiation, four age groups, and seven CD4 groups) based on tracing patients lost in Kenya and data linkages in South Africa were applied. Corrected mortality rates were compared with a worst case scenario assuming all patients lost to follow-up had died. RESULTS: Loss to follow-up differed between regions; rates were lowest in central Africa and highest in east Africa. Compared with using two correction factors (1.64 for the initial ART period and 2.19 for later), applying 168 correction factors (range 1.03-4.75) more often resulted in implausible mortality rates that exceeded the worst case scenario. Corrected mortality rates varied widely, ranging from 0.2 per 100 person-years to 54 per 100 person-years depending on region and covariates. CONCLUSION: Implausible rates were less common with the simpler approach based on two correction factors. The corrected mortality rates will be useful to international agencies, national programmes, and modellers.
Authors: Stephen J Gange; Mari M Kitahata; Michael S Saag; David R Bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore Journal: Int J Epidemiol Date: 2007-01-08 Impact factor: 7.196
Authors: Catherine C McGowan; Pedro Cahn; Eduardo Gotuzzo; Denis Padgett; Jean W Pape; Marcelo Wolff; Mauro Schechter; Daniel R Masys Journal: Int J Epidemiol Date: 2007-09-10 Impact factor: 7.196
Authors: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne Journal: Lancet Date: 2002-07-13 Impact factor: 79.321
Authors: Matthias Egger; Ben D Spycher; John Sidle; Ralf Weigel; Elvin H Geng; Matthew P Fox; Patrick MacPhail; Gilles van Cutsem; Eugène Messou; Robin Wood; Denis Nash; Margaret Pascoe; Diana Dickinson; Jean-François Etard; James A McIntyre; Martin W G Brinkhof Journal: PLoS Med Date: 2011-01-18 Impact factor: 11.069
Authors: Benjamin H Chi; Constantin T Yiannoutsos; Andrew O Westfall; Jamie E Newman; Jialun Zhou; Carina Cesar; Martin W G Brinkhof; Albert Mwango; Eric Balestre; Gabriela Carriquiry; Thira Sirisanthana; Henri Mukumbi; Jeffrey N Martin; Anna Grimsrud; Melanie Bacon; Rodolphe Thiebaut Journal: PLoS Med Date: 2011-10-25 Impact factor: 11.069
Authors: Leigh F Johnson; Rob E Dorrington; Ria Laubscher; Christopher J Hoffmann; Robin Wood; Matthew P Fox; Morna Cornell; Michael Schomaker; Hans Prozesky; Frank Tanser; Mary-Ann Davies; Andrew Boulle Journal: J Int AIDS Soc Date: 2015-12-16 Impact factor: 5.396
Authors: Nanina Anderegg; Jonas Hector; Laura F Jefferys; Juan Burgos-Soto; Michael A Hobbins; Jochen Ehmer; Lukas Meier; Marloes H Maathuis; Matthias Egger Journal: J Clin Epidemiol Date: 2020-08-20 Impact factor: 6.437
Authors: Christopher R Sudfeld; Ferdinand Mugusi; Alfa Muhihi; Said Aboud; Tumaini J Nagu; Nzovu Ulenga; Biling Hong; Molin Wang; Wafaie W Fawzi Journal: Lancet HIV Date: 2020-07 Impact factor: 12.767
Authors: Jessie K Edwards; Giorgos Bakoyannis; Constantin T Yiannoutsos; Margaret W Mburu; Stephen R Cole Journal: Stat Med Date: 2019-10-24 Impact factor: 2.373
Authors: David C Boettiger; Anthony T Newall; Pairoj Chattranukulchai; Romanee Chaiwarith; Suwimon Khusuwan; Anchalee Avihingsanon; Andrew Phillips; Eran Bendavid; Matthew G Law; James G Kahn; Jeremy Ross; Sergio Bautista-Arredondo; Sasisopin Kiertiburanakul Journal: J Int AIDS Soc Date: 2020-06 Impact factor: 5.396
Authors: Thibaut Davy-Mendez; Sonia Napravnik; Brenna C Hogan; Keri N Althoff; Kelly A Gebo; Richard D Moore; Michael A Horberg; Michael J Silverberg; M John Gill; Heidi M Crane; Vincent C Marconi; Ronald J Bosch; Jonathan A Colasanti; Timothy R Sterling; W Christopher Mathews; Angel M Mayor; Ni Gusti Ayu Nanditha; Kate Buchacz; Jun Li; Peter F Rebeiro; Jennifer E Thorne; Ank Nijhawan; David van Duin; David A Wohl; Joseph J Eron; Stephen A Berry Journal: J Infect Dis Date: 2021-06-15 Impact factor: 5.226
Authors: Andreas D Haas; Elizabeth Zaniewski; Nanina Anderegg; Nathan Ford; Matthew P Fox; Michael Vinikoor; François Dabis; Denis Nash; Jean d'Amour Sinayobye; Thêodore Niyongabo; Aristophane Tanon; Armel Poda; Adebola A Adedimeji; Andrew Edmonds; Mary-Ann Davies; Matthias Egger Journal: J Int AIDS Soc Date: 2018-02 Impact factor: 5.396
Authors: Geoffrey Fatti; Debra Jackson; Ameena E Goga; Najma Shaikh; Brian Eley; Jean B Nachega; Ashraf Grimwood Journal: J Int AIDS Soc Date: 2018-02 Impact factor: 5.396
Authors: Frédérique Chammartin; Cam Ha Dao Ostinelli; Kathryn Anastos; Antoine Jaquet; Ellen Brazier; Steven Brown; Francois Dabis; Mary-Ann Davies; Stephany N Duda; Karen Malateste; Denis Nash; Kara Wools-Kaloustian; Per M von Groote; Matthias Egger Journal: BMJ Open Date: 2020-05-15 Impact factor: 2.692